161 related articles for article (PubMed ID: 36375254)
1. IL-33-ILC2 axis promotes anti-tumor CD8
Okuyama Y; Okajima A; Sakamoto N; Hashimoto A; Tanabe R; Kawajiri A; Kawabe T; Ishii N
Biochem Biophys Res Commun; 2022 Dec; 637():9-16. PubMed ID: 36375254
[TBL] [Abstract][Full Text] [Related]
2. Critical role of OX40/OX40L in ILC2-mediated activation of CD4
Wu J; Cui Y; Zhu W; Bai S; Zhao N; Liu B
Int Immunopharmacol; 2019 Nov; 76():105784. PubMed ID: 31470268
[TBL] [Abstract][Full Text] [Related]
3. Requirements for the functional expression of OX40 ligand on human activated CD4+ and CD8+ T cells.
Kondo K; Okuma K; Tanaka R; Zhang LF; Kodama A; Takahashi Y; Yamamoto N; Ansari AA; Tanaka Y
Hum Immunol; 2007 Jul; 68(7):563-71. PubMed ID: 17584577
[TBL] [Abstract][Full Text] [Related]
4. Negative regulation of IL-17 production by OX40/OX40L interaction.
Li J; Li L; Shang X; Benson J; Merle Elloso M; Schantz A; Bracht M; Orlovsky Y; Sweet R
Cell Immunol; 2008; 253(1-2):31-7. PubMed ID: 18501882
[TBL] [Abstract][Full Text] [Related]
5. ILC2-derived IL-9 inhibits colorectal cancer progression by activating CD8
Wan J; Wu Y; Huang L; Tian Y; Ji X; Abdelaziz MH; Cai W; Dineshkumar K; Lei Y; Yao S; Sun C; Su Z; Wang S; Xu H
Cancer Lett; 2021 Apr; 502():34-43. PubMed ID: 33429004
[TBL] [Abstract][Full Text] [Related]
6. Tissue-Restricted Adaptive Type 2 Immunity Is Orchestrated by Expression of the Costimulatory Molecule OX40L on Group 2 Innate Lymphoid Cells.
Halim TYF; Rana BMJ; Walker JA; Kerscher B; Knolle MD; Jolin HE; Serrao EM; Haim-Vilmovsky L; Teichmann SA; Rodewald HR; Botto M; Vyse TJ; Fallon PG; Li Z; Withers DR; McKenzie ANJ
Immunity; 2018 Jun; 48(6):1195-1207.e6. PubMed ID: 29907525
[TBL] [Abstract][Full Text] [Related]
7. Multiple levels of activation of murine CD8(+) intraepithelial lymphocytes defined by OX40 (CD134) expression: effects on cell-mediated cytotoxicity, IFN-gamma, and IL-10 regulation.
Wang HC; Klein JR
J Immunol; 2001 Dec; 167(12):6717-23. PubMed ID: 11739485
[TBL] [Abstract][Full Text] [Related]
8. OX40-OX40L interaction promotes proliferation and activation of lymphocytes via NFATc1 in ApoE-deficient mice.
Yan J; Su H; Xu L; Wang C
PLoS One; 2013; 8(4):e60854. PubMed ID: 23593329
[TBL] [Abstract][Full Text] [Related]
9. OX40 ligand regulates inflammation and mortality in the innate immune response to sepsis.
Karulf M; Kelly A; Weinberg AD; Gold JA
J Immunol; 2010 Oct; 185(8):4856-62. PubMed ID: 20844189
[TBL] [Abstract][Full Text] [Related]
10. Group 2 innate lymphoid cells contribute to IL-33-mediated alleviation of cardiac fibrosis.
Chen WY; Wu YH; Tsai TH; Li RF; Lai AC; Li LC; Yang JL; Chang YJ
Theranostics; 2021; 11(6):2594-2611. PubMed ID: 33456562
[No Abstract] [Full Text] [Related]
11. OX40 ligand expressed in glioblastoma modulates adaptive immunity depending on the microenvironment: a clue for successful immunotherapy.
Shibahara I; Saito R; Zhang R; Chonan M; Shoji T; Kanamori M; Sonoda Y; Kumabe T; Kanehira M; Kikuchi T; So T; Watanabe T; Takahashi H; Iwabuchi E; Tanaka Y; Shibahara Y; Sasano H; Ishii N; Tominaga T
Mol Cancer; 2015 Feb; 14():41. PubMed ID: 25744203
[TBL] [Abstract][Full Text] [Related]
12. Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients.
Blazar BR; Sharpe AH; Chen AI; Panoskaltsis-Mortari A; Lees C; Akiba H; Yagita H; Killeen N; Taylor PA
Blood; 2003 May; 101(9):3741-8. PubMed ID: 12521997
[TBL] [Abstract][Full Text] [Related]
13. OX40L/OX40 axis impairs follicular and natural Treg function in human SLE.
Jacquemin C; Augusto JF; Scherlinger M; Gensous N; Forcade E; Douchet I; Levionnois E; Richez C; Lazaro E; Duffau P; Truchetet ME; Seneschal J; Couzi L; Pellegrin JL; Viallard JF; Schaeverbeke T; Pascual V; Contin-Bordes C; Blanco P
JCI Insight; 2018 Dec; 3(24):. PubMed ID: 30568041
[TBL] [Abstract][Full Text] [Related]
14. A novel type-2 innate lymphoid cell-based immunotherapy for cancer.
Saranchova I; Xia CW; Besoiu S; Finkel PL; Ellis SLS; Kari S; Munro L; Pfeifer CG; Fazli L; Gleave ME; Jefferies WA
Front Immunol; 2024; 15():1317522. PubMed ID: 38524132
[TBL] [Abstract][Full Text] [Related]
15. Group 2 innate lymphoid cells promote TNBC lung metastasis via the IL-13-MDSC axis in a murine tumor model.
Zhao N; Zhu W; Wang J; Liu W; Kang L; Yu R; Liu B
Int Immunopharmacol; 2021 Oct; 99():107924. PubMed ID: 34217145
[TBL] [Abstract][Full Text] [Related]
16. Group 2 innate lymphoid cells boost CD8
Wen J; Cheng S; Wang R; Huang Y; Xu L; Ma L; Ling Z; Xu J; Zhao D; Zhang Y; Sun B
Oncoimmunology; 2023; 12(1):2243112. PubMed ID: 37577145
[TBL] [Abstract][Full Text] [Related]
17. OX40 and OX40L Interaction in Cancer.
Lu X
Curr Med Chem; 2021; 28(28):5659-5673. PubMed ID: 33372866
[TBL] [Abstract][Full Text] [Related]
18. OX40 ligand regulates splenic CD8⁻ dendritic cell-induced Th2 responses in vivo.
Kamachi F; Harada N; Usui Y; Sakanishi T; Ishii N; Okumura K; Miyake S; Akiba H
Biochem Biophys Res Commun; 2014 Feb; 444(2):235-40. PubMed ID: 24462862
[TBL] [Abstract][Full Text] [Related]
19. The Immune Checkpoint Modulator OX40 and Its Ligand OX40L in NK-Cell Immunosurveillance and Acute Myeloid Leukemia.
Nuebling T; Schumacher CE; Hofmann M; Hagelstein I; Schmiedel BJ; Maurer S; Federmann B; Rothfelder K; Roerden M; Dörfel D; Schneider P; Jung G; Salih HR
Cancer Immunol Res; 2018 Feb; 6(2):209-221. PubMed ID: 29321210
[TBL] [Abstract][Full Text] [Related]
20. OX40 ligand is inhibitory during the effector phase of crescentic glomerulonephritis.
Odobasic D; Ruth AJ; Oudin V; Kitching AR; Holdsworth SR
Nephrol Dial Transplant; 2019 Mar; 34(3):429-441. PubMed ID: 29939347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
